We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current HBIO market cap is 17.47M. The company's latest EPS is USD -0.2806 and P/E is -1.43.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 24.51M | 23.1M | 21.97M | 24.56M | 21.77M |
| Operating Income | -2.28M | -2.07M | -3.47M | 11k | -49.67M |
| Net Income | -4.69M | -2.93M | -4.8M | 18k | -50.34M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 102.1M | 118.9M | 113.57M | 112.25M | 94.14M |
| Operating Income | 221k | 2.07M | -6.93M | 1.89M | -6.21M |
| Net Income | -7.81M | -288k | -9.52M | -3.42M | -12.41M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 133.16M | 128.91M | 131.24M | 126.64M | 79.8M |
| Total Liabilities | 64.35M | 61.67M | 65.92M | 63.3M | 64.97M |
| Total Equity | 68.81M | 67.25M | 65.32M | 63.34M | 14.84M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 156.25M | 162.34M | 145.36M | 137.37M | 126.64M |
| Total Liabilities | 79.57M | 78.94M | 73.14M | 64.29M | 63.3M |
| Total Equity | 76.68M | 83.4M | 72.22M | 73.07M | 63.34M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.4M | 557k | -285k | 1.44M | 2.99M |
| Investing | -225k | 233k | -878k | -1.34M | -683k |
| Financing | -1.06M | -878k | 1.23M | -131k | -1.2M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 9.33M | 1.26M | 1.15M | 14.03M | 1.44M |
| Investing | -1.4M | -1.35M | -1.59M | -1.8M | -1.34M |
| Financing | -7.97M | -252k | -2.84M | -12.13M | -131k |
| Market Cap | 17.47M |
| Price to Earnings Ratio | -1.43 |
| Price to Sales Ratio | 0.19 |
| Price to Cash Ratio | 4.31 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 44.21M |
| Average Volume (1 week) | 603.97k |
| Average Volume (1 Month) | 1.11M |
| 52 Week Change | -88.24% |
| 52 Week High | 3.60 |
| 52 Week Low | 0.2813 |
| Spread (Intraday) | 0.01 (2.5%) |
| Company Name | Harvard Bioscience Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.harvardbioscience.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
